Holen Sie sich die Stockscreener-App
92.70
0.18%
0.17
Schlusskurs vom Vortag:
$92.53
Offen:
$92.35
24-Stunden-Volumen:
11.50M
Relative Volume:
1.18
Marktkapitalisierung:
$137.42B
Einnahmen:
$19.35B
Nettoeinkommen (Verlust:
$2.78B
KGV:
49.58
EPS:
1.8696
Netto-Cashflow:
$3.82B
1W Leistung:
-5.96%
1M Leistung:
-8.14%
6M Leistung:
-6.68%
1J Leistung:
+2.77%
1-Tages-Spanne:
$91.86
$93.55
1-Wochen-Bereich:
$91.86
$99.27
52-Wochen-Spanne:
$85.98
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
New insurance policy benefits Boston Scientific Intracept procedure - MassDevice
Boston Scientific Stock Is Dropping: Reasons Behind BSX Sell-Off - EBC Financial Group
A Look Into Boston Scientific Inc's Price Over Earnings - Benzinga
Boston Scientific Corporation $BSX Shares Purchased by State Street Corp - MarketBeat
Boston Scientific buys major Minneapolis-area property for $188M - NBC Boston
Boston Scientific pays $188 million for newly built Minn. facility - The Business Journals
Boston Scientific (BSX): Evaluating Valuation After Fresh Evidence of Sustained Growth in Minimally Invasive Devices - Yahoo Finance
Is Boston Scientific’s (BSX) Aggressive R&D Push Quietly Redefining Its Long‑Term Growth Story? - Yahoo Finance
Boston Scientific pays $188 million for newly built Maple Grove facility - The Business Journals
Boston Scientific Corporation $BSX is Bollard Group LLC's Largest Position - MarketBeat
Boston Scientific Corporation $BSX Shares Bought by Baird Financial Group Inc. - MarketBeat
Boston Scientific Corporation (BSX): A Bull Case Theory - Finviz
Boston Sci brings next-generation Rezūm EVO Console to the UK - BioWorld MedTech
Has Boston Scientific’s Strong Runway in Minimally Invasive Therapies Stretched Its Valuation? - Yahoo Finance
Boston Scientific gets European nod for Farapoint catheter - MassDevice
Sinuscope Market Forecast Report 2032 | Olympus Corporation, - openPR.com
What valuation ratios show for Boston Scientific Corporation stockWatch List & High Accuracy Swing Entry Alerts - Newser
Why Boston Scientific Corporation stock remains on buy lists2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Boston Scientific Corporation (NYSE:BSX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets - ts2.tech
Boston Scientific put volume heavy and directionally bearish - TipRanks
Quantbot Technologies LP Grows Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Insiders Sell US$2.4m Of Stock, Possibly Signalling Caution - Yahoo Finance
Groupe la Francaise Purchases 297,049 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Executive Sells Over $1.7 Million in Company Stock - TradingView
Boston Scientific executive exercises options, sells 17,313 shares | BSX SEC FilingForm 4 - Stock Titan
M&A Strategy Strengthens Boston Scientific's Growth Prospects - Yahoo Finance
Fisher Asset Management LLC Acquires 939,834 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Arrowstreet Capital Limited Partnership - MarketBeat
Boston Sci's Farapoint secures CE mark - BioWorld MedTech
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
[144] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
This investor loves Boston Scientific - Cantech Letter
Boston Scientific Corporation $BSX Stock Holdings Increased by West Family Investments Inc. - MarketBeat
Boston Scientific Corp (BSX.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Will Boston Scientific Corporation stock outperform tech sector in 2025Quarterly Trade Summary & Short-Term High Return Strategies - BỘ NỘI VỤ
New York State Common Retirement Fund Sells 20,594 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Acquired by Mackenzie Financial Corp - MarketBeat
Laurel Wealth Advisors LLC Increases Stock Position in Boston Scientific Corporation $BSX - MarketBeat
What Could Shift the Story for Boston Scientific After Strong Results and Analyst Optimism - Yahoo Finance
How buybacks impact Boston Scientific Corporation stock value2025 Market Sentiment & Real-Time Volume Analysis - BỘ NỘI VỤ
Boston Scientific Corporation $BSX Shares Acquired by CreativeOne Wealth LLC - MarketBeat
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Finviz
Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Boston Scientific Corporation $BSX Shares Sold by Korea Investment CORP - MarketBeat
Is Boston Scientific Stock Underperforming the Nasdaq? - Barchart.com
Why this money manager is buying Boston Scientific and trimming BlackRock - The Globe and Mail
Choreo LLC Buys 3,211 Shares of Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific (NYSE:BSX) A Risky Investment? - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific's Margins Strengthen in Q3: What's Driving It? - Yahoo Finance
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):